Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway

Tao Li(Shandong Provincial QianFoShan Hospital), Jie Li(Shandong Provincial QianFoShan Hospital)
Oncology Reports
April 20, 2016
Cited by 35


Related Papers